CTRI/2023/02/049391
Not yet recruiting
未知
Prevalence and determinants of cognitive impairment among the general population in Coastal Karnataka
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kasturba Medical College
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adult males and females aged 40 years and above who give a written informed consent
- •2\. Subjects who can understand either Kannada or English language.
- •3\. For validating MoCA, participants who can understand both Kannada and Hindi languages
Exclusion Criteria
- •1\. Participants with physical disability in their dominant hand preventing them from performing activities pertaining to the study.
- •2\. Participants who are bedridden
- •3\. Participants with aphasia
- •4\. Participants with visual impairment and hearing loss
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
After the patient has bleed into brain, the patient memory loss will be assessed in a survived patient after 6 months.Health Condition 1: null- Patients who had survived an episode of ICHCTRI/2018/01/011062Kasthurba medical college
Completed
Not Applicable
Study of the prevalence of cognitive deficits in paraplegics undergoing inpatient hospital treatment.G82Paraplegia and tetraplegiaDRKS00031766BG Klinikum Hamburg137
Not yet recruiting
Phase 3
The survey to find out the number of individuals having difficulty in remembering or learning new things and its effect on mobility and balance in elderly population in Hubli DharwadCTRI/2019/09/021124Chougule Snehal Sanjay
Completed
Not Applicable
ature and mechanisms of cognitive deficits following chemotherapy: an (f)MRI studycognitive deficitsmemory and concentration problems10009841NL-OMON34510Antoni van Leeuwenhoek Ziekenhuis180
Completed
Not Applicable
nravelling brain mechanisms of cognitive impairment in breast cancer patients during adjuvant endocrine treatmentbreast cancer1000629110006232NL-OMON37354Radboud Universiteit Nijmegen150